glp 1 nomi commerciali Farmaci anti-obesità: quali effetti su pancreas e reni? GLP-1 Medications Clinic Near Me

Tirzepatide, a dual GIP/GLP-1 receptor agonist, has demonstrated greater efficacy in clinical trials, including the head-to-head SURMOUNT-5 trial comparing it to semaglutide 2.4 mg, potentially producing more substantial weight loss than traditional GLP-1 agonists alone

GLP-1 medications have been life changing for so many people with obesity, says Jody Dushay, MD, an assistant professor of medicine at Harvard Medical School and an endocrinologist at the Beth Israel Deaconess Medical Center in Boston

The risks of being overweight Higher risk of cardiovascular disease and high blood pressure

doi: 10.1038/s41574-024-00952-6

10.1002/2211-5463.13499 12 ChopraS.GiovanelliP.Alvarado-VazquezP